Ron Perelman's $410m insurance trial is testing the limits of art valuation
The Art Newspaper
JULY 18, 2025
The insurers dispute the damage, as well as Perelman’s claim that he never attempted to sell the works afterward. It’s a challenge that is familiar from authenticity and attribution cases. According to court filings, he had reportedly used the works (and many others since sold) as collateral for loans.
206 
Let's personalize your content